Commercial funding | Personal income* | Per capita payment | Researcher patent | University patent | Researcher stocks | University stocks | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
H | B | D | H | B | D | H | B | D | H | B | D | H | B | D | H | B | D | H | B | D | |
H indicates heart disease group (n = 2355), B indicates breast cancer group (n = 1006), and D indicates depression group (n = 2117). | |||||||||||||||||||||
*For the personal income scenario only, the respondents were given an extra response option for the informed consent requirement, inclination, and behaviour questions to assess whether the amount of personal income received by the researcher was a determining factor. The amount categories were: greater than $100, greater than $1000, greater than $5000, greater than $10 000, greater than $50 000. For the behaviour question in this scenario, “unsure” response was not an option. | |||||||||||||||||||||
†IC indicates informed consent. The majority of respondents felt that financial arrangement information contained in all seven scenarios was extremely or very important. For all scenarios, a clear majority (range 64% to 87%) responded that researchers should be required to disclose the financial arrangements. | |||||||||||||||||||||
Importance | |||||||||||||||||||||
Extremely/very | 56 | 62 | 51 | 58 | 69 | 56 | 50 | 61 | 46 | 59 | 64 | 59 | 56 | 65 | 57 | 66 | 72 | 65 | 64 | 69 | 62 |
Somewhat | 27 | 26 | 31 | 24 | 19 | 26 | 27 | 23 | 26 | 21 | 21 | 21 | 24 | 22 | 24 | 17 | 15 | 19 | 19 | 18 | 21 |
Not very/at all | 17 | 12 | 19 | 17 | 12 | 18 | 23 | 16 | 28 | 20 | 15 | 20 | 20 | 14 | 20 | 17 | 13 | 17 | 17 | 13 | 18 |
IC requirement† | |||||||||||||||||||||
Yes | 81 | 87 | 78 | 68 | 74 | 64 | 70 | 78 | 64 | 76 | 82 | 75 | 76 | 82 | 74 | 80 | 85 | 78 | 79 | 84 | 76 |
Yes, depends on amount | – | – | – | 7 | 9 | 10 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Inclination | |||||||||||||||||||||
More | 46 | 42 | 41 | 16 | 10 | 11 | 17 | 12 | 13 | 12 | 11 | 9 | 16 | 16 | 15 | 8 | 5 | 6 | 8 | 6 | 7 |
Same as before | 50 | 52 | 53 | 53 | 46 | 50 | 68 | 65 | 70 | 62 | 67 | 60 | 72 | 75 | 70 | 55 | 59 | 54 | 66 | 69 | 65 |
Less | 3 | 6 | 6 | 22 | 31 | 28 | 16 | 23 | 17 | 26 | 23 | 31 | 12 | 10 | 15 | 37 | 36 | 40 | 26 | 24 | 28 |
Less, depends on amount | – | – | – | 8 | 13 | 11 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Behaviour | |||||||||||||||||||||
Still consider | 89 | 82 | 86 | 79 | 67 | 70 | 83 | 74 | 80 | 75 | 72 | 68 | 86 | 84 | 80 | 65 | 61 | 59 | 71 | 68 | 66 |
Unsure | 9 | 16 | 12 | 10 | 15 | 11 | 12 | 17 | 14 | 8 | 11 | 11 | 18 | 26 | 21 | 17 | 23 | 20 | |||
Not participate | 2 | 3 | 3 | 12 | 18 | 18 | 7 | 11 | 9 | 13 | 11 | 17 | 5 | 5 | 9 | 17 | 14 | 20 | 12 | 10 | 14 |
Not participate, depends on amount | – | – | – | 9 | 14 | 12 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |